Guangzhou KOFA Biotechnology

Guangzhou KOFA Biotechnology is a high-tech enterprise specializing in the research, development, production, and sales of in vitro diagnostic (IVD) reagents and instruments. Founded in 2011 and headquartered in Guangzhou, China, the company focuses on point-of-care testing (POCT) solutions across various clinical fields including cardiovascular disease, inflammation, diabetes, and renal function. KOFA utilizes advanced technologies such as fluorescence immunochromatography and latex-enhanced immunoturbidimetry to provide rapid and accurate diagnostic results. Their product portfolio includes a range of automated analyzers and a comprehensive menu of test kits used in hospitals and clinics worldwide. The company is committed to improving healthcare efficiency through innovative diagnostic tools and maintains a strong presence in both domestic and international markets.